{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-000461","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2022-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.232808+00:00","generated_at":"2026-06-26T06:49:06.562355+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"IGC obtains final court approval of shareholder class action settlement; lawsuits dismissed","bullets":["Court granted final approval of settlement on April 13, 2022, dismissing Tchatchou and Harris-Carr consolidated class actions.","Settlement resolves all shareholder class action lawsuits pending against IGC and its officers.","Most settlement costs paid through company's insurance policy; terms previously disclosed in Form 10-Q filed Feb 10, 2022.","IGC continues Alzheimer's drug development with IGC-AD1, a THC-based investigational drug; Phase 2 trial planned."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-000461","json":"https://secwatch.observer/filing/0001185185-22-000461.json","markdown":"https://secwatch.observer/filing/0001185185-22-000461.md","text":"https://secwatch.observer/filing/0001185185-22-000461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522000461/0001185185-22-000461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518522000461/indiaglob20220418_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T06:49:06.562355+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}